Denali Therapeutics Stock Forecast - Naive Prediction
| DNLI Stock | USD 25.00 0.16 0.64% |
The Naive Prediction forecasted value of Denali Therapeutics on the next trading day is expected to be 24.39 with a mean absolute deviation of 0.93 and the sum of the absolute errors of 56.87. Denali Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Denali Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
Denali |
Denali Therapeutics Cash Forecast
Predicting cash flow or other financial metrics requires analysts to utilize a variety of statistical methods, techniques, and algorithms. These tools help uncover hidden patterns in the Denali Therapeutics' financial statements, enabling forecasts of their impact on future stock prices.
Cash | First Reported 2015-12-31 | Previous Quarter 74.7 M | Current Value 90.6 M | Quarterly Volatility 138.8 M |
Denali Therapeutics Naive Prediction Price Forecast For the 30th of November
Given 90 days horizon, the Naive Prediction forecasted value of Denali Therapeutics on the next trading day is expected to be 24.39 with a mean absolute deviation of 0.93, mean absolute percentage error of 1.46, and the sum of the absolute errors of 56.87.Please note that although there have been many attempts to predict Denali Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Denali Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Denali Therapeutics Stock Forecast Pattern
| Backtest Denali Therapeutics | Denali Therapeutics Price Prediction | Buy or Sell Advice |
Denali Therapeutics Forecasted Value
In the context of forecasting Denali Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Denali Therapeutics' downside and upside margins for the forecasting period are 20.96 and 27.83, respectively. We have considered Denali Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Denali Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Denali Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 118.4916 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.9322 |
| MAPE | Mean absolute percentage error | 0.0341 |
| SAE | Sum of the absolute errors | 56.8669 |
Predictive Modules for Denali Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Denali Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for Denali Therapeutics
For every potential investor in Denali, whether a beginner or expert, Denali Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Denali Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Denali. Basic forecasting techniques help filter out the noise by identifying Denali Therapeutics' price trends.View Denali Therapeutics Related Equities
| Risk & Return | Correlation |
Denali Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Denali Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Denali Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Denali Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Denali Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Denali Therapeutics shares will generate the highest return on investment. By undertsting and applying Denali Therapeutics stock market strength indicators, traders can identify Denali Therapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 9313.61 | |||
| Daily Balance Of Power | (0.26) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 25.12 | |||
| Day Typical Price | 25.08 | |||
| Price Action Indicator | (0.20) | |||
| Period Momentum Indicator | (0.16) |
Denali Therapeutics Risk Indicators
The analysis of Denali Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Denali Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting denali stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.26 | |||
| Semi Deviation | 3.51 | |||
| Standard Deviation | 3.38 | |||
| Variance | 11.43 | |||
| Downside Variance | 13.28 | |||
| Semi Variance | 12.29 | |||
| Expected Short fall | (2.14) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
When determining whether Denali Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Denali Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Denali Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Denali Therapeutics Stock:Check out Historical Fundamental Analysis of Denali Therapeutics to cross-verify your projections. For more detail on how to invest in Denali Stock please use our How to Invest in Denali Therapeutics guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Denali Therapeutics. If investors know Denali will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Denali Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.76) | Quarterly Revenue Growth (1.00) | Return On Assets (0.24) | Return On Equity (0.35) |
The market value of Denali Therapeutics is measured differently than its book value, which is the value of Denali that is recorded on the company's balance sheet. Investors also form their own opinion of Denali Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Denali Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Denali Therapeutics' market value can be influenced by many factors that don't directly affect Denali Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Denali Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Denali Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Denali Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.